These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


63 related items for PubMed ID: 5128900

  • 21. [Mechanism of action of factor XIII on the structure of fibrin in normal subjects and in disease].
    Kleĭmenov AN, Rozenfel'd MA, Piruzian LA, Titova MI, Shimkevich LL.
    Izv Akad Nauk SSSR Biol; 1978; (5):764-8. PubMed ID: 711986
    [No Abstract] [Full Text] [Related]

  • 22. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE, Santiago MA, Greenberg CS.
    Anal Biochem; 1994 May 15; 219(1):43-8. PubMed ID: 8059954
    [Abstract] [Full Text] [Related]

  • 23. [Quantitative determination of the fibrin-stabilizing factor].
    Radzevich IM.
    Ukr Biokhim Zh; 1969 May 15; 41(3):311-7. PubMed ID: 5389719
    [No Abstract] [Full Text] [Related]

  • 24. Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.
    Hevessy Z, Haramura G, Boda Z, Udvardy M, Muszbek L.
    Thromb Haemost; 1996 Jan 15; 75(1):161-7. PubMed ID: 8713796
    [Abstract] [Full Text] [Related]

  • 25. [Preparation of fibrin monomer from fibrin of unfractionated blood plasma].
    Radzevich IM, Khodorova EL.
    Ukr Biokhim Zh; 1969 Jan 15; 41(4):367-70. PubMed ID: 5392265
    [No Abstract] [Full Text] [Related]

  • 26. The difference between platelet and plasma FXIII used to study the mechanism of platelet microvesicle formation.
    Holme PA, Brosstad F, Solum NO.
    Thromb Haemost; 1993 Oct 18; 70(4):681-6. PubMed ID: 8115996
    [Abstract] [Full Text] [Related]

  • 27. [Fibrin stabilizing factor].
    Konishi K, Takagi T.
    Tanpakushitsu Kakusan Koso; 1970 Dec 18; 15(14):1441-51. PubMed ID: 5530020
    [No Abstract] [Full Text] [Related]

  • 28. Proceedings: Characterisitics of platelet protransglutaminase (factor XIII)-binding activity in human plasma.
    Bannerjee D, Mosesson MW.
    Thromb Diath Haemorrh; 1975 Nov 15; 34(2):549. PubMed ID: 1198414
    [No Abstract] [Full Text] [Related]

  • 29. Platelet accumulation on fibrin-coated polyethylene: role of platelet activation and factor XIII.
    Rubens FD, Perry DW, Hatton MW, Bishop PD, Packham MA, Kinlough-Rathbone RL.
    Thromb Haemost; 1995 May 15; 73(5):850-6. PubMed ID: 7482415
    [Abstract] [Full Text] [Related]

  • 30. Packaging zinc, fibrinogen, and factor XIII in platelet alpha-granules.
    Marx G, Korner G, Mou X, Gorodetsky R.
    J Cell Physiol; 1993 Sep 15; 156(3):437-42. PubMed ID: 8360253
    [Abstract] [Full Text] [Related]

  • 31. Complete covalent structure of human platelet factor 4.
    Morgan FJ, Begg GS, Chesterman CN.
    Thromb Haemost; 1980 Feb 29; 42(5):1652-60. PubMed ID: 6445090
    [Abstract] [Full Text] [Related]

  • 32. [Blood platelets and fibrin stabilizing factor activity].
    Isobe J, Kawano K, Yamanaka M.
    Nihon Ketsueki Gakkai Zasshi; 1970 Oct 29; 33(5):696-7. PubMed ID: 5535827
    [No Abstract] [Full Text] [Related]

  • 33. Separation of plasma and platelet factor XIII by gel filtration.
    McDonagh J, Wagner RH.
    Am J Physiol; 1970 Dec 29; 219(6):15558. PubMed ID: 5485672
    [No Abstract] [Full Text] [Related]

  • 34. [The significance of changes in the functional properties of blood platelets, factor XIII activity and fibrin clot quality in the pathogenesis of hemorrhagic diathesis secondary to experimental vitamin C deficiency].
    Sushkevich GN, Khnychev SS, Oĭvin VI.
    Vopr Pitan; 1969 Dec 29; 28(5):23-7. PubMed ID: 5370913
    [No Abstract] [Full Text] [Related]

  • 35. In vivo radiolabeling of platelet proteins: a new method with identification of platelet factor XIII.
    Rider DM, McDonagh RP, McDonagh J.
    Blood; 1980 Apr 29; 55(4):559-63. PubMed ID: 7357084
    [Abstract] [Full Text] [Related]

  • 36. Immunocytochemical localization of albumin and factor XIII in thin cryo sections of human blood platelets.
    Sixma JJ, van den Berg A, Schiphorst M, Geuze HJ, McDonagh J.
    Thromb Haemost; 1984 Jul 29; 51(3):388-91. PubMed ID: 6388014
    [Abstract] [Full Text] [Related]

  • 37. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL, Lukacova D.
    Thromb Haemost; 1995 Aug 29; 74(2):680-5. PubMed ID: 8585006
    [Abstract] [Full Text] [Related]

  • 38. Lysis of clots prepared from whole blood and plasma.
    Taylor FB, Carroll RC, Gerrard J, Esmon CT, Radcliffe RD.
    Fed Proc; 1981 May 15; 40(7):2092-8. PubMed ID: 7194803
    [No Abstract] [Full Text] [Related]

  • 39. [Separation of factor VIII and factor XIII from human plasma (author's transl)].
    Fukui H, Mikami S, Okuda T, Murashima N.
    Nihon Ketsueki Gakkai Zasshi; 1976 Apr 15; 39(2):163-9. PubMed ID: 1036863
    [No Abstract] [Full Text] [Related]

  • 40. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
    Sakata Y, Aoki N.
    J Clin Invest; 1980 Feb 15; 65(2):290-7. PubMed ID: 6444305
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.